HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Guo Selected Research

2,2'-dipicolylamine

1/2022Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Guo Research Topics

Disease

87Neoplasms (Cancer)
12/2022 - 05/2006
32Stroke (Strokes)
09/2022 - 03/2014
29Infections
02/2022 - 03/2009
24Inflammation (Inflammations)
10/2022 - 04/2010
16Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2005
16Breast Neoplasms (Breast Cancer)
01/2022 - 03/2012
14Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2012
13Ischemic Stroke
01/2022 - 04/2016
13Hepatocellular Carcinoma (Hepatoma)
03/2020 - 07/2010
12Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 09/2014
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2013
10Neoplasm Metastasis (Metastasis)
12/2022 - 08/2010
10Body Weight (Weight, Body)
02/2022 - 05/2016
10Glioma (Gliomas)
01/2022 - 01/2017
10Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2007
9Liver Neoplasms (Liver Cancer)
01/2022 - 10/2016
8Hypertension (High Blood Pressure)
01/2022 - 11/2015
8Sepsis (Septicemia)
05/2021 - 04/2016
8Insulin Resistance
01/2020 - 06/2011
8Myocardial Infarction
01/2019 - 03/2013
7Obesity
01/2022 - 05/2016
7Cognitive Dysfunction
01/2022 - 01/2019
7Vascular Diseases (Vascular Disease)
12/2021 - 01/2016
7Cerebral Hemorrhage
01/2021 - 04/2016
7Diabetes Mellitus
10/2020 - 03/2013
7Fibrosis (Cirrhosis)
10/2020 - 01/2013
6COVID-19
05/2022 - 01/2020
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2012
6Melanoma (Melanoma, Malignant)
06/2021 - 01/2017
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 09/2015
6Hemorrhage
01/2018 - 03/2013
5Hypoxia (Hypoxemia)
03/2022 - 04/2009
5Necrosis
01/2022 - 03/2008
5Liver Diseases (Liver Disease)
01/2022 - 12/2016
5Carcinogenesis
04/2021 - 04/2009
5Bacterial Infections (Bacterial Infection)
01/2021 - 01/2014
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2015
5Fatty Liver
01/2021 - 12/2016
5Heart Diseases (Heart Disease)
01/2020 - 03/2014
5Wounds and Injuries (Trauma)
01/2019 - 04/2012
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 08/2010
4Chronic Renal Insufficiency
12/2022 - 07/2014
4Heart Failure
12/2022 - 03/2013
4Atrial Fibrillation
01/2022 - 07/2014
4Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 01/2018
4Prostatic Neoplasms (Prostate Cancer)
11/2021 - 01/2013
4Epilepsy (Aura)
11/2021 - 01/2016
4Mental Disorders (Mental Disorder)
11/2021 - 01/2015
4Chronic Disease (Chronic Diseases)
10/2021 - 03/2012
4Brain Neoplasms (Brain Tumor)
10/2021 - 01/2014
4Dyspepsia (Indigestion)
11/2020 - 12/2016
4Squamous Cell Carcinoma of Head and Neck
11/2020 - 04/2012
4Stomach Neoplasms (Stomach Cancer)
10/2020 - 01/2014
3Neuroinflammatory Diseases
08/2022 - 07/2013

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2009
38Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2010
24Pharmaceutical PreparationsIBA
02/2022 - 01/2009
18Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2014
15LipidsIBA
01/2022 - 01/2016
14Biological ProductsIBA
05/2022 - 10/2016
10Blood Glucose (Blood Sugar)IBA
01/2022 - 04/2016
9EnzymesIBA
12/2022 - 06/2007
9RNA (Ribonucleic Acid)IBA
12/2021 - 05/2006
8CytokinesIBA
02/2022 - 12/2016
8Therapeutic UsesIBA
01/2022 - 04/2010
8ORALIT (ORS)IBA
01/2022 - 04/2014
8Indicators and Reagents (Reagents)IBA
01/2022 - 04/2012
8TeaIBA
01/2022 - 05/2016
8Messenger RNA (mRNA)IBA
01/2020 - 03/2012
7Insulin (Novolin)FDA Link
10/2022 - 05/2012
7Small Interfering RNA (siRNA)IBA
01/2022 - 06/2013
6Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 01/2018
6DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2014
6MicroRNAs (MicroRNA)IBA
11/2020 - 09/2013
5C-Reactive ProteinIBA
12/2021 - 04/2010
5Amyloid (Amyloid Fibrils)IBA
12/2021 - 07/2013
5Antiviral Agents (Antivirals)IBA
06/2021 - 03/2012
5Caspase 3 (Caspase-3)IBA
03/2021 - 01/2015
5EverolimusFDA Link
01/2020 - 03/2015
4Neuroprotective AgentsIBA
08/2022 - 07/2013
4Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 01/2021
4CholesterolIBA
01/2022 - 01/2007
4Interleukin-18 (Interleukin 18)IBA
01/2022 - 03/2015
4Long Noncoding RNAIBA
01/2022 - 01/2020
4IronIBA
01/2022 - 04/2010
4Glutamic Acid (Glutamate)FDA Link
01/2022 - 04/2018
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 01/2007
4Peptide Hydrolases (Proteases)FDA Link
01/2020 - 03/2009
4Anti-Bacterial Agents (Antibiotics)IBA
07/2019 - 02/2013
4Peptides (Polypeptides)IBA
07/2018 - 04/2005

Therapy/Procedure

44Therapeutics
06/2022 - 05/2006
10Drug Therapy (Chemotherapy)
12/2022 - 01/2014
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 03/2008
8Percutaneous Coronary Intervention
01/2020 - 05/2014
7Radiotherapy
01/2020 - 01/2012
6Immunotherapy
12/2021 - 01/2019
6Stents
01/2020 - 07/2014
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2016 - 07/2015
4Length of Stay
05/2022 - 05/2014
4Ligation
01/2021 - 10/2019